Trial
NCT04528199
[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
FutureChem
Condition
Metastatic Prostate Cancer
Intervention
[18F]FLOR (FC303) Injection
Why stopped
The Principal Investigator decided to terminate the study because the PI left Hopkins.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-16